Noosa News
Demand for weight-loss treatments opens new markets for Tasmania’s poppy industry
A shortage of the weight-loss drug Ozempic to treat type 2 diabetes has opened up new markets for the Tasmanian alkaloid poppy sector.
It’s the shot in the arm northern Tasmanian pharmaceutical business Extractas Bioscience needed.
For nearly a decade the poppy processor has struggled with a…
Continue Reading
-
General23 hours agoAustralia Kangaroos lose Xavier Coates and Zac Lomax ahead of rugby league Ashes in England
-
General9 hours agoPolice investigating after body found on road in Newborough, Gippsland
-
Noosa News24 hours agoWorker rushed to hospital after becoming trapped in machinery during horror workplace accident in Salisbury
-
General21 hours agoThe Church of England’s ‘turning point’ to irrelevancy